Gut Microbiota Impairs Flutamide Efficacy in Prostate Cancer Treatment
Gut bacteria metabolize Flutamide into inactive forms, reducing its therapeutic efficacy against prostate cancer.
Asset / Drug
Drug and asset intelligence for Flutamide with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.